Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Citi
Federal Trade Commission
Queensland Health
Merck
Moodys
US Department of Justice
Harvard Business School
US Army

Generated: April 20, 2018

DrugPatentWatch Database Preview

PARADIONE Drug Profile

« Back to Dashboard

Which patents cover Paradione, and when can generic versions of Paradione launch?

Paradione is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in PARADIONE is paramethadione. Additional details are available on the paramethadione profile page.
Drug patent expirations by year for PARADIONE
Synonyms for PARADIONE
115-67-3
115P673
118328-EP2275420A1
118328-EP2280008A2
118328-EP2298764A1
118328-EP2298765A1
2,4-Oxazolidinedione, 5-ethyl-3,5-dimethyl-
3,5-Dimethyl-5-ethyloxazolidine-2,4-dione
4-27-00-03255 (Beilstein Handbook Reference)
5-Ethyl-3,5-dimethyl-1,3-oxazolidine-2,4-dione
5-Ethyl-3,5-dimethyl-1,3-oxazolidine-2,4-dione #
5-Ethyl-3,5-dimethyl-2,4-oxazolidinedione
5-ethyl-3,5-dimethyl-4-oxazolidinedione
5-ethyl-3,5-dimethyl-oxazolidine-2,4-dione
5-Ethyl-3,5-dimethyloxazolidine-2,4-dione
5-ethyl-3,5-dimethyloxazolidine-2.4-dione
A 348
A-348
AB01563081_01
AC1L1QNH
AKOS006239791
AN-5685
BRN 0127715
C07411
C7H11NO3
CCG-213441
CHEBI:7921
CHEMBL1100
CTK6D0119
D00495
D09JBP
DB00617
DTXSID8023420
EINECS 204-098-8
GTPL7261
HE001110
HE298619
HMS3264I11
HSDB 3245
I14-43844
Isoethadione
LS-100334
MolPort-003-666-699
NCGC00183600-01
NSC-760129
NSC760129
Paradione (TN)
Parametadiona
Parametadiona [INN-Spanish]
Parametadione
Parametadione [DCIT]
PARAMETHADIONE
paramethadione (500 mg)
Paramethadione (INN)
Paramethadione [BAN:INN]
Paramethadione [INN:BAN]
Paramethadionum
Paramethadionum [INN-Latin]
Pharmakon1600-01505456
SBI-0206930.P001
SCHEMBL34857
SR-05000002060
SR-05000002060-1
VQASKUSHBVDKGU-UHFFFAOYSA-N
Z2327506990

US Patents and Regulatory Information for PARADIONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie PARADIONE paramethadione CAPSULE;ORAL 006800-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie PARADIONE paramethadione CAPSULE;ORAL 006800-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie PARADIONE paramethadione SOLUTION;ORAL 006800-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Queensland Health
US Army
Accenture
Express Scripts
Cantor Fitzgerald
Mallinckrodt
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.